Abstract Background Many prognostic risk scores have been developed for ambulatory Heart Failure (HF) patients, but none of these has validated in Dilated Cardiomyopathy (DCM), that is a peculiar model HF. Aims To evaluate and compare the applicability performance major HF models large real-world population DCM patients Methods This was retrospective study including 784 consecutive non ischemic...

Heart failure (HF) is one of the leading causes of morbidity, mortality, and health care expenditures in the US and worldwide. For three decades, the pillars of treatment of HF with reduced ejection fraction (HFrEF) were medications that targeted the sympathetic nervous system (SNS) and the renin-angiotensin-aldosterone system (RAAS). Prior attempts to augment the natriuretic peptide system (NP...

Predictive Score for 30-Day Readmission or Death in Heart Failure Readmissions shortly after heart failure (HF) are common, expensive, and usually considered preventable.1 However, despite the use of several interventions, rates of readmission after HF remain stable.2 An effective risk score might permit the targeting of resource-intensive interventions (such as disease-management programs) spe...

eart failure (HF) has become the major epidemic of the ew millennium, and use of the left ventricular (LV) assist evice (LVAD) for mechanical support in end-stage HF is ncreasing. Introduced as an alternative to heart transplanation, LVADs were approved by the Food and Drug dministration a decade ago to provide a bridge to translantation in the moribund end-stage HF patient waiting or a donor h...

heart failure (hf) is one of the main causes of death and disability in the world. the prevalence of hf in developed countries is between 1% and 2% of the adult population and approximately between 6% and 10% in the elderly, giving rise to high costs of care and treatment. indeed, in the united states, the direct and indirect costs exceeded 23 billion dollars in 2002.  hf is typically character...

The frequently occurring condition of renal failure in heart failure (HF) has been termed the cardiorenal syndrome. However, the importance of renal insufficiency in HF has only been embraced in the last decade, and therefore, the pathophysiology of cardiorenal failure is still poorly understood. The main driving force of renal failure in HF is probably hemodynamic derangement, with both reduce...

Risk stratification in heart failure (HF) patients is an important element for management. There are several risk stratification models that can be used to predict the prognosis of patients with HF, such as Aaronson's scale, CVM-HF (CardioVascular Medicine Heart Failure), the Seattle Heart Failure Model (SHFM) and the Munich score. These models fail to adequately address the impact of multiorga...

Background Heart failure with preserved ejection fraction (HF-PEF) is common and has a poor prognosis with a 3 year mortality rate of 23%. There are currently no effective therapies for this condition. HF-PEF is characterized by symptoms of heart failure, normal or a mildly impaired ejection fraction and evidence of adverse cardiac and vascular remodelling. A feature of all heart failure is a h...

Subject Codes: 110 (congestive heart failure), 26 (exercise) df df df df df df dfie ie ie ie ie ie ield ld ld ld ld ld ABSTRACT Background: When advanced, heart failure (HF) with preserved ejection fraction (HFpEF) is

Heart failure (HF) is the cause of impaired exercise capacity due to insufficient peripheral blood flow. Development natriuretic peptide (NP) through inhibition neprilysin enzyme therapeutic target in HF. Treatment with sacubitril/valsartan has been shown significantly reduce mortality and hospitalization rehospitalization rates for HF compared enalapril. Sacubitril/valsartan may provide signif...